Description
Product Properties
|
Alternative Names |
CD135, FLK2, STK-1, FLT-3 |
|
Species |
Human |
|
Expression Sequence |
Asn27-Asn541 |
|
Accession |
P36888-1 |
|
Tag |
C-His-Avi |
|
Expression System |
CHO |
|
Molecular Weight |
The protein has a predicted MW of 61.20 kDa. Due to glycosylation, the protein migrates to 80-110 kDa based on SDS-PAGE result. |
|
Purity |
> 95% as determined by SDS-PAGE and HPLC. |
|
Endotoxin |
< 1.0 EU per μg by the LAL method. |
|
Formulation |
Supplied as 0.22μm filtered solution in PBS (pH 7.4). |
|
Appearance |
Liquid |
|
Biological Activity |
【ELISA Data】Immobilized Human FLT3 Ligand, hFc Tag at 0.5μg/ml (100μl/well) on the plate. Dose response curve for Biotinylated Human FLT3, His Tag with the EC50 of 0.26μg/ml determined by ELISA. |
Features
High purity, high activity, low endotoxin, high batch-to-batch consistency
Storage
Store at -85 ~ -65℃, valid for 1 year after receipt. Avoid repeated freezing and thawing, and centrifuge before opening the vial. It is recommended to aliquot for one experiment, and freeze at -80℃ after aliquoting.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.